ZYME · trading date Oct 14, 2026 · previous close $25.06 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$105.97M
Net income
-$81.13M
Total assets
$346.53M
Total liabilities
$78.03M
Stockholders' equity
$268.50M
Cash & equivalents
$41.16M
Operating income
-$92.55M
Operating cash flow
-$33.01M
Capital expenditures
$1.52M
Fiscal year 2025, via 10-K filed 2026-03-02.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-87.3%
Net margin
-76.6%
Free cash flow
-$34.53M
Free cash flow margin
-32.6%
Liabilities / assets
22.5%
Equity / assets
77.5%
CapEx / revenue
1.4%
Operating cash flow / net income
0.41×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Middletown, DE 19709
108 PATRIOT DRIVE, SUITE A
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.